- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Lymphoma
Clinical Trial Search
Trial Protocol ID
D8227C00002_ACRUE
Investigator
John Wallmark, M.D.
A Prospective, Open-Label, Single-Arm, Phase II Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With Diffuse Large B-Cell Lymphoma (ACRUE)
Trial Protocol ID
USOR 18263_BGB-3111-215 *STAR*
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib
Trial Protocol ID
BGB-11417-201
Investigator
Mohit Narang, M.D.
A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of
Bcl-2 Inhibitor BGB-11417 in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Trial Protocol ID
USOR 22041_M23-362
Investigator
Syed Shahid Mahmood, M.D.
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting
Trial Protocol ID
RGX-104-001
Investigator
John Wallmark, M.D.
A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies